Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy
Kevin K. Millis(Harvard University), Samuel Singer(Memorial Sloan Kettering Cancer Center), David G. Cory(University of Waterloo), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Patrick Weybright(Harvard University), Natalee Campbell(Brigham and Women's Hospital), Jonathan A. Fletcher(Harvard University)
Magnetic Resonance in Medicine
February 1, 1999
Cited by 90
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
|Nature Biotechnology|2000|1.7k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
|Nature Genetics|2010|725
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716